# FDA Inspection 801077 - AstraZeneca AB - May 29, 2012

Source: https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-ab/6d5eec9b-907b-44e4-92ac-4d6897e18186
Source feed: FDA_Inspections

> FDA Inspection 801077 for AstraZeneca AB on May 29, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 801077
- Company Name: AstraZeneca AB
- Inspection Date: 2012-05-29
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1295446 - 2025-11-13](https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-ab/d32ae4f0-e390-4008-8537-3964ee831aa5)
- [FDA Inspection 1295446 - 2025-11-13](https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-ab/cdd672be-aff7-4d71-b0b9-07278fe90867)
- [FDA Inspection 1295446 - 2025-11-13](https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-ab/e2646f33-6680-4ec2-b07d-d81ccb236a8b)
- [FDA Inspection 1248230 - 2022-12-01](https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-ab/27c718fa-7c43-4bb4-8673-10c7d64f0095)
- [FDA Inspection 1143443 - 2019-12-06](https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-ab/fb0cf60c-b8c2-4b62-a38b-90562becb871)

Company: https://www.globalkeysolutions.net/companies/astrazeneca-ab/b85a1aa5-9a0c-4c1e-996d-70b40b2507de

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c